nasovax
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 18, 2017 (NCT03232567)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04442230 | Phase 2 | Oct 10, 2020 | Altimmune, Inc. |
| NCT03232567 | Phase 2 | Sep 18, 2017 | Altimmune, Inc., Optimal Research |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Altimmune, Inc. | For profit | 2 | 2 | 1 | 2017 |
| Optimal Research | For profit | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1